Author Correction: FOXA1 mutations alter pioneering activity, differentiation and prostate cancer phenotypes

Affiliations

• ¹ Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
• ² Sandra and Edward Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.
• ³ Department of Urology, Weill Cornell Medicine, New York, NY, USA.
• ⁴ HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsaud Institute for Computational Biomedicine, Weill Cornell Medical College, New York, NY, USA.
• ⁵ Center for Epigenetics Research, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
• ⁶ Louis V. Gerstner Jr Graduate School of Biomedical Sciences, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
• ⁷ Computational and Systems Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
• ⁸ Physiology, Biophysics, and Systems Biology Program, Weill Cornell Graduate School, New York, NY, USA.
• ⁹ Tri-Institutional Training Program in Computational Biology & Medicine, Weill Cornell Medicine, New York, NY, USA.
• ¹⁰ GenomeDx Bioscience, Vancouver, British Columbia, Canada.
• ¹¹ Englander Institute for Precision Medicine of Weill Cornell Medicine and NewYork-Presbyterian Hospital, New York, NY, USA.
• ¹² Departments of Anatomy, Medicine and Urology, University of California, San Francisco, San Francisco, CA, USA.
• ¹³ Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA. [email protected].
• ¹⁴ Howard Hughes Medical Institute, Chevy Chase, MD, USA. [email protected].